Contineum Therapeutics, Inc. ($CTNM)
Lorrain Daniel S. โ Chief Scientific Officer
Shares
1,015
Price
$0.00
Total Value
$0.00
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Lorrain Daniel S. |
|---|---|
| Title | Chief Scientific Officer |
| Transaction Date | Jul 8, 2026 |
| Expiration Date | Feb 24, 2030 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Disposed |
| Security | Stock Option (right to buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Jul 10, 2026 |
| Shares Purchased | 1,015 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 33,282 |
| Derivative | Derivative |
| Accession Number | 0001628280-26-047909 |
| Document | View SEC Filing |